If the author’s manuscript is assessed as inappropriate to be published in his/her preferred journal, our editorial team may help the author in transferring the submission to a more appropriate Bentham Journal, through Bentham’s Manuscript Transfer Facility.
Transfer of Submission
Transfer of submission with Bentham’s Manuscript Transfer Facility is very simple.
The Author receives the transfer proposal by email - the transfer process is initiated by an affirmative response from the author to our transfer proposal.
The Authors’ manuscript is transferred to a suitable journal for initial editorial scrutiny.
The Author then receives an editorial decision from the journal.
Selection of another Journal
The Author is free to choose to submit the manuscript to a new journal by declining our transfer offer.
Our aim is to facilitate and develop rapid, effective and truly innovative solutions to facilitate our valued authors by enabling more options and better services to improve the publication process.
Robert Powers University of Nebraska-Lincoln Lincoln, NE USA
Dr. Robert Powers is currently a Professor of Chemistry at the University of Nebraska-Lincoln. He has more than 30 years of experience in NMR spectroscopy, structural biology, metabolomics, and drug discovery. He received his BA from Rutgers University, a Ph.D. in chemistry fromt Purdue University, and was a postdoctoral fellow at the NIH laboratory of Chemical Physics. Prior to arriving at UNL, Dr. Powers was an Associate Director for the Protein NMR group at Wyeth. Dr. Powers is the Editor-in-Chief of Current Metabolomics and has written over 120 peer-reviewed manuscripts, 5 book chapters, and is an inventor on 9 patents.
Dave Watson BSc PhD PGCE is a reader in Pharmaceutical Sciences at the University of Strathclyde up He has specialised in chromatographic methods combined with mass spectrometry which he has applied to a range of problems ranging from drug metabolism and disposition through to metabolomics. He published a popular undergraduate textbook on Pharmaceutical Analysis textbook on Pharmaceutical Chemistry. He has been first supervisor for 45 completed PhD students and currently has a group of 18 PhD students. He has published 280 papers and reviews. He was local organiser and chair of the 2013 Metabolomics Conference which was held in Glasgow. Current interests include: mass spectrometric metabolomics in Crohn’s disease, metal toxicity, metabolic syndrome, exercise and immunology.